Skip to main navigation Skip to search Skip to main content

P-30 Screening of Hybrid Arylidene Heterocyclic Boronic Acids as Potential Anticancer Agents in AU565 HER2/neu Breast Cancer Cell Line

  • Andrews University

Research output: Contribution to conferencePoster

Original languageAmerican English
StatePublished - Nov 4 2016

Disciplines

  • Biology

Cite this